483
Atul VermaAtul Verma – FDA 483, Aug 11, 2023
Record Details
An FDA inspection of clinical investigator Atul Verma, M.D. identified a significant issue regarding the conduct of a clinical study. The firm failed to follow good clinical practice for record accuracy, specifically noting discrepancies between source documentation and the electronic database for the Medtronic MDT 16027 clinical study. This indicates a failure to properly investigate and maintain accurate records for patient data.
View Company Profile
ID · ae75e9dc-4c9a-47c0-afbe-6917693c7beb
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.